Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)
NCT07118280 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-01-27
Summary
The goal of this observational study is to explore whether oral health and saliva viscosity and composition in Oculopharyngeal Muscular Dystrophy (OPMD) is different from control subjects.
The main questions it aims to answer are:
Do swallowing disturbances in OPMD adversely affect oral health? Is saliva thickness (viscosity) is increased in OPMD? Does saliva in OPMD contains biochemical markers of the disease?
Conditions
- Oculopharyngeal Muscular Dystrophy
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth
NCT00750828 ·Status: COMPLETED
-
Salivary Flow Rate and Oral Function
NCT01020084 ·Status: COMPLETED
-
Saliva and Dental Calculus in Handicapped People
NCT00495989 ·Status: COMPLETED ·Phase: NA
-
A Stimulator of the Salivary Vibration of the Parotid Glands
NCT05129111 ·Status: COMPLETED ·Phase: NA
-
Can Saliva be the New Bio-fluid to Monitor Children's Oral Health?
NCT05495373 ·Status: COMPLETED
-
Characterization of Diseases With Salivary Gland Involvement
NCT02327884 ·Status: RECRUITING
-
Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders
NCT03679988 ·Status: UNKNOWN
-
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
NCT02068846 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders
NCT07318922 ·Status: NOT_YET_RECRUITING
-
Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
NCT03192358 ·Status: COMPLETED
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Salivary Flow and Buffer Capacity Associated to Aged People's Oral Health
NCT00651248 ·Status: COMPLETED
-
NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy
NCT02107300 ·Status: COMPLETED ·Phase: NA
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
Nasal Xylitol in the Prevention of Otitis Media
NCT02592382 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052 ·Status: COMPLETED ·Phase: NA
-
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
NCT00001852 ·Status: COMPLETED
-
Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease
NCT04212572 ·Status: UNKNOWN
-
The Oral Symptom Assessment Scale in Older Patients With Frailty
NCT06286982 ·Status: COMPLETED
-
Evaluation of Salivary Gland Dysfunction
NCT00001196 ·Status: TERMINATED
-
Effect of Pilocarpine in Patients With Xerostomia
NCT02982577 ·Status: UNKNOWN ·Phase: PHASE4
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Influence of Two Paraffin Wax Chewing Gums of Different Consistency on the Stimulated Saliva Flow Rate
NCT04661761 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia
NCT04581486 ·Status: UNKNOWN ·Phase: NA